CN Patent

CN105017169A — 一种4-（4-环丙基萘-1-基）-5-硫代-[1,2,4]三唑烷-3-酮的制备方法及其中间体（4-环丙基萘-1-基）-氨基甲酸乙酯

Assigned to ANHUI WANBANG MEDICAL TECHNOLOGY Co Ltd · Expires 2015-11-04 · 11y expired

What this patent protects

本发明提供了一种4-（4-环丙基萘-1-基）-5-硫代-[1,2,4]三唑烷-3-酮的制备方法及其中间体（4-环丙基萘-1-基）-氨基甲酸乙酯，该中间体用于合成抗痛风药Lesinurad，具有经济性、环保性、高效性及产率高等优点。

USPTO Abstract

本发明提供了一种4-（4-环丙基萘-1-基）-5-硫代-[1,2,4]三唑烷-3-酮的制备方法及其中间体（4-环丙基萘-1-基）-氨基甲酸乙酯，该中间体用于合成抗痛风药Lesinurad，具有经济性、环保性、高效性及产率高等优点。

Drugs covered by this patent

Zurampic (LESINURAD) · Ironwood Pharms Inc

Patent Metadata

Patent number: CN105017169A
Jurisdiction: CN
Classification: —
Expires: 2015-11-04
Drug substance claim: No
Drug product claim: No
Assignee: ANHUI WANBANG MEDICAL TECHNOLOGY Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.